NSE filing, NSE: ESDS. Summary written from the filing by ALFA Finder's alert engine.
ESDS Software Solution Ltd: key numbers
- Share price
- ₹1,147.70
- Market cap
- ₹13,452 Cr
- Revenue (annual)
- ₹472.2 Cr
- Net profit (annual)
- ₹120.3 Cr
- Promoter holding
- 39.47%
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ESDS Software Solution Ltd
All →ESDS Software Solution Annual General Meeting
ESDS Software Solution will hold its 21st AGM on November 30, 2026, via VC/OAVM with remote e-voting. Resolutions cover financial statements, director re-appointment, auditor appointment, and ESOP ratifications.
ESDS Software Solution Annual Report
ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.
ESDS Software Solution Other Announcement
ESDS Software reported no deviation in utilisation of its IPO proceeds for the quarter ended September 30, 2026. The Reg 32 statement is a routine compliance disclosure.
ESDS Software Solution Earnings Call Transcript: Key Takeaways
Q2 revenue ₹138.3 Cr, +3.5% QoQ; H1 revenue +24.6%, PAT +26.3% YoY. Growth hinges on Sharon AI GPU go-live, now targeted December 2026.
ESDS Software Solution Investor Presentation: Key Takeaways
H1FY27 revenue ₹2,719.9Mn (+24.6% YoY), PAT ₹603.7Mn (+26.3%), EBITDA margin 41.8%. Q2FY27 revenue ₹1,383.4Mn (+47.5% YoY, +3.5% QoQ). Large GPUaaS contract is the key growth driver.
ESDS Software Solution Results Update
ESDS Software Solution reported Q2FY27 revenue up 48% YoY to Rs 1,383.4 million and PAT up 40.7%. H1FY27 revenue rose 25% YoY, with EBITDA margin at 41.8%.
Other product launch announcements
All →HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum